ECT2 and lung carcinoma: Similarly, ROC analyses showed that DLGAP5 and ECT2 levels could also robustly distinguish lung cancer patients from normal subjects, demonstrating high AUC, specificity and sensitivity values (Fig. 4B–C, Table 3).